Market Closed -
Toronto S.E.
15:43:25 09/05/2024 BST
|
5-day change
|
1st Jan Change
|
0.01
CAD
|
-33.33%
|
|
0.00%
|
0.00%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
8.291
|
12.86
|
58.06
|
27.13
|
6.667
|
2.977
|
Enterprise Value (EV)
1 |
13.14
|
16.67
|
61.46
|
29.95
|
10.84
|
7.433
|
P/E ratio
|
-7.23
x
|
-3.97
x
|
-21.9
x
|
-20.9
x
|
-2.93
x
|
-1.55
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
37.5
x
|
57.9
x
|
512
x
|
241
x
|
-
|
-
|
EV / Revenue
|
59.4
x
|
75
x
|
542
x
|
266
x
|
-
|
-
|
EV / EBITDA
|
-13.1
x
|
-13.7
x
|
-43.5
x
|
-16
x
|
-5.24
x
|
-4.64
x
|
EV / FCF
|
-15.6
x
|
219
x
|
-27.4
x
|
-12.2
x
|
-10.1
x
|
-8.02
x
|
FCF Yield
|
-6.42%
|
0.46%
|
-3.66%
|
-8.22%
|
-9.86%
|
-12.5%
|
Price to Book
|
-1.62
x
|
-2.33
x
|
-15.3
x
|
-11.8
x
|
-2.02
x
|
-0.83
x
|
Nbr of stocks (in thousands)
|
165,828
|
214,357
|
247,073
|
258,419
|
266,669
|
297,700
|
Reference price
2 |
0.0500
|
0.0600
|
0.2350
|
0.1050
|
0.0250
|
0.0100
|
Announcement Date
|
31/07/19
|
27/04/20
|
29/04/21
|
29/04/22
|
28/04/23
|
29/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
0.2211
|
0.2223
|
0.1134
|
0.1125
|
-
|
-
|
EBITDA
1 |
-1.006
|
-1.217
|
-1.412
|
-1.871
|
-2.067
|
-1.603
|
EBIT
1 |
-1.091
|
-1.301
|
-1.495
|
-1.957
|
-2.151
|
-1.686
|
Operating Margin
|
-493.65%
|
-585.27%
|
-1,318.28%
|
-1,739.69%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-1.143
|
-2.772
|
-2.417
|
-1.315
|
-2.291
|
-1.861
|
Net income
1 |
-1.143
|
-2.772
|
-2.417
|
-1.273
|
-2.26
|
-1.828
|
Net margin
|
-516.94%
|
-1,246.64%
|
-2,132.17%
|
-1,132.09%
|
-
|
-
|
EPS
2 |
-0.006912
|
-0.0151
|
-0.0107
|
-0.005014
|
-0.008529
|
-0.006433
|
Free Cash Flow
1 |
-0.8439
|
0.0763
|
-2.247
|
-2.461
|
-1.069
|
-0.9273
|
FCF margin
|
-381.7%
|
34.31%
|
-1,981.79%
|
-2,187.46%
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
31/07/19
|
27/04/20
|
29/04/21
|
29/04/22
|
28/04/23
|
29/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
4.85
|
3.81
|
3.4
|
2.82
|
4.17
|
4.46
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-4.82
x
|
-3.13
x
|
-2.408
x
|
-1.505
x
|
-2.017
x
|
-2.779
x
|
Free Cash Flow
1 |
-0.84
|
0.08
|
-2.25
|
-2.46
|
-1.07
|
-0.93
|
ROE (net income / shareholders' equity)
|
24%
|
51.6%
|
51.9%
|
51.2%
|
123%
|
73.2%
|
ROA (Net income/ Total Assets)
|
-50.8%
|
-46.2%
|
-44.7%
|
-53%
|
-49.3%
|
-36.1%
|
Assets
1 |
2.25
|
6.002
|
5.405
|
2.402
|
4.58
|
5.065
|
Book Value Per Share
2 |
-0.0300
|
-0.0300
|
-0.0200
|
-0.0100
|
-0.0100
|
-0.0100
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
0
|
0
|
Capex
|
-
|
-
|
0.01
|
1.11
|
0.54
|
0.39
|
Capex / Sales
|
-
|
-
|
8.1%
|
986.9%
|
-
|
-
|
Announcement Date
|
31/07/19
|
27/04/20
|
29/04/21
|
29/04/22
|
28/04/23
|
29/04/24
|
|
1st Jan change
|
Capi.
|
---|
| 0.00% | 3.62M | | +14.75% | 8.94B | | +37.33% | 2.36B | | -10.73% | 1.05B | | +21.40% | 854M | | -8.19% | 778M | | +19.65% | 654M | | +12.26% | 649M | | -12.79% | 609M | | -4.05% | 577M |
Purification & Treatment Equipment
|